Kidney function, proteinuria and breast arterial calcification in women without clinical cardiovascular disease: The MINERVA study

Background Breast arterial calcification (BAC) may be a predictor of cardiovascular events and is highly prevalent in persons with end-stage kidney disease. However, few studies to date have examined the association between mild-to-moderate kidney function and proteinuria with BAC. Methods We prospectively enrolled women with no prior cardiovascular disease aged 60 to 79 years undergoing mammography screening at Kaiser Permanente Northern California between 10/24/2012 and 2/13/2015. Urine albumin-to-creatinine ratio (uACR), along with specific laboratory, demographic, and medical data, were measured at the baseline visit. Baseline estimated glomerular filtration rate (eGFR), medication history, and other comorbidities were identified from self-report and/or electronic medical records. BAC presence and gradation (mass) was measured by digital quantification of full-field mammograms. Results Among 3,507 participants, 24.5% were aged ≥70 years, 63.5% were white, 7.5% had eGFR <60 ml/min/1.73m2, with 85.7% having uACR ≥30 mg/g and 3.3% having uACR ≥300 mg/g. The prevalence of any measured BAC (>0 mg) was 27.9%. Neither uACR ≥30 mg/g nor uACR ≥300 were significantly associated with BAC in crude or multivariable analyses. Reduced eGFR was associated with BAC in univariate analyses (odds ratio 1.53, 95% CI: 1.18–2.00), but the association was no longer significant after adjustment for potential confounders. Results were similar in various sensitivity analyses that used different BAC thresholds or analytic approaches. Conclusions Among women without cardiovascular disease undergoing mammography screening, reduced eGFR and albuminuria were not significantly associated with BAC.

[1]  I. Sechopoulos,et al.  Progression of Medial Arterial Calcification in CKD , 2018, Kidney international reports.

[2]  H. Ding,et al.  MultIethNic Study of BrEast ARterial Calcium Gradation and CardioVAscular Disease: cohort recruitment and baseline characteristics. , 2017, Annals of epidemiology.

[3]  Anna C. Porter,et al.  Coronary Artery Calcification and Risk of Cardiovascular Disease and Death Among Patients With Chronic Kidney Disease , 2017, JAMA cardiology.

[4]  P. Greenland,et al.  Breast Arterial Calcification: Expanding the Reach of Cardiovascular Prevention. , 2017, Circulation.

[5]  P. Slanetz,et al.  Do breast arterial calcifications on mammography predict elevated risk of coronary artery disease? , 2016, European journal of radiology.

[6]  W. Mali,et al.  Medial Arterial Calcification: Active Reversible Disease in Human Breast Arteries. , 2015, JACC Cardiovascular Imaging.

[7]  W. Mali,et al.  Breast arterial calcifications: a systematic review and meta-analysis of their determinants and their association with cardiovascular events. , 2015, Atherosclerosis.

[8]  W. C. O'Neill,et al.  Breast arterial calcification in chronic kidney disease: absence of smooth muscle apoptosis and osteogenic transdifferentiation. , 2014, Kidney international.

[9]  Z. Massy,et al.  Vascular calcification in chronic kidney disease: a review. , 2013, Jornal brasileiro de nefrologia : 'orgao oficial de Sociedades Brasileira e Latino-Americana de Nefrologia.

[10]  S. Molloi,et al.  Breast Arterial Calcification: a New Marker of Cardiovascular Risk? , 2013, Current Cardiovascular Risk Reports.

[11]  C. D'Orsi,et al.  The risk for medial arterial calcification in CKD. , 2012, Clinical journal of the American Society of Nephrology : CJASN.

[12]  Michiel L Bots,et al.  Added value of CAC in risk stratification for cardiovascular events: a systematic review , 2012, European journal of clinical investigation.

[13]  Carl J D'Orsi,et al.  Breast arterial calcification: a marker of medial vascular calcification in chronic kidney disease. , 2011, Clinical journal of the American Society of Nephrology : CJASN.

[14]  B. Kestenbaum,et al.  Incidence and progression of coronary calcification in chronic kidney disease: the Multi-Ethnic Study of Atherosclerosis. , 2009, Kidney international.

[15]  D. Singer,et al.  The Net Clinical Benefit of Warfarin Anticoagulation in Atrial Fibrillation , 2009, Annals of Internal Medicine.

[16]  P. Schirmacher,et al.  Arterial calcification in patients with chronic kidney disease. , 2009, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[17]  D. Towler,et al.  Vascular calcification: the killer of patients with chronic kidney disease. , 2009, Journal of the American Society of Nephrology : JASN.

[18]  C. Schmid,et al.  A new equation to estimate glomerular filtration rate. , 2009, Annals of internal medicine.

[19]  D. Singer,et al.  Impact of Proteinuria and Glomerular Filtration Rate on Risk of Thromboembolism in Atrial Fibrillation: The Anticoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study , 2009, Circulation.

[20]  A. Go,et al.  Response to Newly Prescribed Lipid-Lowering Therapy in Patients With and Without HIV Infection , 2009, Annals of Internal Medicine.

[21]  A. Go,et al.  Comparative effectiveness of different beta-adrenergic antagonists on mortality among adults with heart failure in clinical practice. , 2008, Archives of internal medicine.

[22]  K. Amann Media calcification and intima calcification are distinct entities in chronic kidney disease. , 2008, Clinical journal of the American Society of Nephrology : CJASN.

[23]  Tracy A. Lieu,et al.  The Cardiovascular Research Network: A New Paradigm for Cardiovascular Quality and Outcomes Research , 2008, Circulation. Cardiovascular quality and outcomes.

[24]  A. Go,et al.  The risk of acute renal failure in patients with chronic kidney disease. , 2008, Kidney international.

[25]  Sabee Molloi,et al.  Quantification of breast arterial calcification using full field digital mammography. , 2008, Medical physics.

[26]  Sharon M Moe,et al.  Mechanisms of vascular calcification in chronic kidney disease. , 2008, Journal of the American Society of Nephrology : JASN.

[27]  A. Go,et al.  GFR, body mass index, and low high-density lipoprotein concentration in adults with and without CKD. , 2007, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[28]  A. Go,et al.  Traditional and novel risk factors for clinically diagnosed abdominal aortic aneurysm: the Kaiser multiphasic health checkup cohort study. , 2007, Annals of epidemiology.

[29]  A. Go,et al.  Comparative effectiveness of beta-adrenergic antagonists (atenolol, metoprolol tartrate, carvedilol) on the risk of rehospitalization in adults with heart failure. , 2007, The American journal of cardiology.

[30]  A. Go,et al.  Statin therapy and risks for death and hospitalization in chronic heart failure. , 2006, JAMA.

[31]  A. Go,et al.  Hemoglobin Level, Chronic Kidney Disease, and the Risks of Death and Hospitalization in Adults With Chronic Heart Failure: The Anemia in Chronic Heart Failure: Outcomes and Resource Utilization (ANCHOR) Study , 2006, Circulation.

[32]  J. Floege,et al.  Calcification and Cardiovascular Health: New Insights Into an Old Phenomenon , 2006, Hypertension.

[33]  A. Go,et al.  Statin and -Blocker Therapy and the Initial Presentation of Coronary Heart Disease , 2006, Annals of Internal Medicine.

[34]  Carlos Iribarren,et al.  Breast vascular calcification and risk of coronary heart disease, stroke, and heart failure. , 2004, Journal of women's health.

[35]  A. Levin,et al.  Vascular calcification in chronic kidney disease. , 2004, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[36]  G. London,et al.  Arterial media calcification in end-stage renal disease: impact on all-cause and cardiovascular mortality. , 2003, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[37]  Jennifer Y. Liu,et al.  Ethnic disparities in diabetic complications in an insured population. , 2002, JAMA.

[38]  D. Singer,et al.  Warfarin Use among Ambulatory Patients with Nonvalvular Atrial Fibrillation: The AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study , 1999, Annals of Internal Medicine.

[39]  C. Reutelingsperger,et al.  Vascular calcification in chronic kidney disease: an update. , 2016, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[40]  J. Stockman,et al.  A New Equation to Estimate Glomerular Filtration Rate , 2011 .